Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

The Non-Malignant Channel: Anemias

Explore the latest updates and expert interviews

The Non-Malignant Channel: Anemias on VJHemOnc is supported by Agios Pharmaceuticals The supporter has no influence over the production of the content.

Welcome to The Anemias Channel.

VJHemOnc brings you the latest updates in anemias directly from world-leading experts. The Anemias Channel brings you video interviews, as well as informative podcasts and feature articles.

Discover key developments in this space, including updates in disease biology, novel treatment strategies, and ongoing clinical trials.

Aplastic Anemia

View all
Incidence & management of TA-TMA in settings with limited access to biomarkers and targeted therapy 2:38
Incidence & management of TA-TMA in settings with limited access to biomarkers and targeted therapy
Nour Ben Abdeljelil • 23 Mar 2026
Bridging therapy options for patients with aplastic anemia and selecting between them 3:02
Bridging therapy options for patients with aplastic anemia and selecting between them
Juan Montoro • 26 Mar 2025
The impact of donor types in alloSCT with PTCy for severe aplastic anemia 2:42
The impact of donor types in alloSCT with PTCy for severe aplastic anemia
Juan Montoro • 26 Mar 2025
Factors to consider when selecting a patient with aplastic anemia for transplantation 3:47
Factors to consider when selecting a patient with aplastic anemia for transplantation
Juan Montoro • 26 Mar 2025

Sickle Cell Disease

View all
Optimizing the delivery of care for patients with hemoglobinopathies in the UK 2:27
Optimizing the delivery of care for patients with hemoglobinopathies in the UK
Farrukh Shah • 30 Apr 2024
Blood group genotyping program to improve transfusion outcomes in hemoglobinopathies 1:55
Blood group genotyping program to improve transfusion outcomes in hemoglobinopathies
Sara Trompeter • 26 Oct 2023
Comparing adverse pregnancy outcomes in patients with SCD vs anemia 1:09
Comparing adverse pregnancy outcomes in patients with SCD vs anemia
Lydia Pecker • 26 Oct 2023
Genetic modifiers affecting the response to hydroxyurea in children with sickle cell anemia 2:47
Genetic modifiers affecting the response to hydroxyurea in children with sickle cell anemia
Miguel Brito • 27 Oct 2023

Thalassemia

View all
Optimizing the delivery of care for patients with hemoglobinopathies in the UK 2:27
Optimizing the delivery of care for patients with hemoglobinopathies in the UK
Farrukh Shah • 30 Apr 2024
Treating transfusion dependent and independent beta-thalassemia, and BELIEVE/BEYOND trial updates 8:38
Treating transfusion dependent and independent beta-thalassemia, and BELIEVE/BEYOND trial updates
Maria Domenica Cappellini • 8 Dec 2023
Blood group genotyping program to improve transfusion outcomes in hemoglobinopathies 1:55
Blood group genotyping program to improve transfusion outcomes in hemoglobinopathies
Sara Trompeter • 26 Oct 2023
Results of the BELIEVE study: luspatercept for the treatment of beta-thalassemia 2:28
Results of the BELIEVE study: luspatercept for the treatment of beta-thalassemia
Maria Domenica Cappellini • 27 Oct 2023
The Non-Malignant Channel: Anemias on VJHemOnc is supported by Agios Pharmaceuticals The supporter has no influence over the production of the content.
If you are interested in becoming a supporter of The Non-Malignant Channel, please contact us

Choose your cookie settings

VJHemOnc uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.

Cookie Policy (opens in a new tab)
The content of VJHemOnc is intended for healthcare professionals